Personalizing Cancer Supportive Care: Predicting Neutropenic Complications in Patients Receiving Intermediate Risk Cancer Chemotherapy

被引：0
|
作者：
Lyman, Gary H. [1 ,2 ]
Culakova, Eva [1 ]
Poniewierski, Marek S. [1 ]
Crawford, Jeffrey [1 ]
Dale, David C. [3 ]
Kuderer, Nicole M. [1 ]
机构：
[1] Duke Univ, Durham, NC USA
[2] Duke Canc Inst, Durham, NC USA
[3] Univ Washington, Seattle, WA 98195 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：469 / 469
页数：1
相关论文
共 50 条
  • [21] Comparative Effectiveness of Filgrastim, Pegfilgrastim, and Sargramostim as Prophylaxis Against Hospitalization for Neutropenic Complications in Patients With Cancer Receiving Chemotherapy
    Weycker, Derek
    Malin, Jennifer
    Barron, Rich
    Edelsberg, John
    Kartashov, Alex
    Oster, Gerry
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (03): : 267 - 274
  • [22] Prospective validation of a risk model for first cycle neutropenic complications in early-stage breast cancer patients receiving adjuvant chemotherapy.
    Lyman, G. H.
    Kuderer, N. M.
    Crawford, J.
    Wolff, D. A.
    Culakova, E.
    Poniewierski, M. S.
    Dale, D. C.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S283 - S284
  • [23] The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients
    Klastersky, J
    Paesmans, M
    Rubenstein, EB
    Boyer, M
    Elting, L
    Feld, R
    Gallagher, J
    Herrstedt, J
    Rapoport, B
    Rolston, K
    Talcott, J
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) : 3038 - 3051
  • [24] Risk and Consequences of Neutropenic Complications Among Patients with Metastatic Solid Tumors Receiving Myelosuppressive Chemotherapy
    Weycker, Derek
    Li, Xiaoyan
    Kartashov, Alex
    Barron, Rich
    Edelsberg, John
    Xu, Hairong
    Girardi, Vincent
    Lyman, Gary H.
    BLOOD, 2013, 122 (21)
  • [25] Risk of neutropenic complications based on a prospective nationwide registry of cancer patients initiating systematic chemotherapy.
    Wolff, DA
    Crawford, J
    Dale, DC
    Poniewierski, MS
    Lyman, GH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 549S - 549S
  • [26] Infectious complications in neutropenic cancer patients
    Menichetti, Francesco
    INTERNAL AND EMERGENCY MEDICINE, 2010, 5 : S21 - S25
  • [27] Infectious complications in neutropenic cancer patients
    Francesco Menichetti
    Internal and Emergency Medicine, 2010, 5 : 21 - 25
  • [28] Potential drug interactions in cancer patients receiving supportive care exclusively
    Riechelmann, Rachel P.
    Zimmermann, Camilla
    Chin, Sheray N.
    Wang, Lisa
    O'Carroll, Aoife
    Zarinehbaf, Sanaz
    Krzyzanowska, Monika K.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2008, 35 (05) : 535 - 543
  • [29] Risk factors for neutropenic fever in lymphoma patients receiving chemotherapy
    Teegala, S. R.
    Zhou, X.
    Huen, A.
    Ji, Y.
    Fayad, L. E.
    Romaguera, J. E.
    Vadhan-Raj, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] RISK OF MAJOR BLEEDING IN CANCER PATIENTS RECEIVING CHEMOTHERAPY
    Zong, J. H.
    Eckert, L.
    Zhang, L.
    Dai, W. S.
    Cohen, A. T.
    Lyman, G. H.
    ANNALS OF ONCOLOGY, 2012, 23 : 447 - 447
12345